Agenda of the 22nd annual meeting
Speakers book 22nd annual meeting
Conclusions from the 22nd DCVMN Annual General Meeting
Commentary published in #vaccineswork. pertaining to Conclusions from the 22nd DCVMN Annual General Meeting on the DCVMN website
https://www.gavi.org/vaccineswork/conclusions-22nd-dcvmn-annual-general-meeting
Tuesday, 19th October 2021
Wednesday, 20th October 2021
Thursday, 21st October 2021
PRESENTATIONS
2021 Annual General Meeting presentation materials available for download (PDF):
Tuesday, 19th October 2021
Session 1 – Inaugural Session
- D1 S1 2 Bruce Aylward_ACT-A The Vaccine Pillar Success Strategies
- D1 S1 5 David Kaslow_ PATH CVIA plenary
Session 2 – Innovations in vaccine space
- D1 S2 4 Aurelia Nguyen_COVAX Facility 2021 and beyond
- D1 S2 6 Jerome Kim_IVI Actions taken towards developing accessible vaccines
Session 3 – CEO Forum: Vision 2030
Wednesday, 20th October 2021
Session 2 – Challenges & Opportunities in Vaccine Research & Availability
- D1 S3 5 Sinergium Biotech
- D2 S2 1 Melanie Saville_COVAX Manufacturing Task Force achievements and challenges ahead
- D2 S2 2 Etleva Kadilli_Perspectives of EPI vaccines distribution recovery affected by COVID-19
- D2 S2 3 Pieter Neels_How the COVID-19 vaccines received EUL in less than 12 months from the day secquence was made available
- D2 S2 4 Kate O Brien_ Impact of C-19 on r.i. and mitigation strategies
- D2 S2 Carmen Rodriguez_ WHO EUL updates
- D2 S2 6 Raman Rao_Facilitating tech transfers in LIMCs
Session 3- Innovative Financing Mechanisms to ramp up Manufacturing in Africa and other LMICs
- D2 S3 5 Kelvin Lee_ Supporting capability in HR resources
- D2 S3 6 Lin Xiangliang_Esco Aster_ Contract Mfgs an essencial part of pandemic response
- D2 S3 7 Jon Pearman_Temptime Zebra_ Breakthoughs in VVMs
Thursday, 21st October 2021
Session 1 – Priorities & Policies for LMICs – A multilateral View
- D3 S1 1_Gagandeep Kang_ Adopting New Technologies
- D3 S1 2 Frank Cobelens_ TB vaccine roadmap
- D3 S1 5 Tania Cernuschi_ Market Information for Access M14A
- D3 S1 6 Frederik Kristensen_ Enabiling vaccine R&D and Manufacturing in LMICs
- D3 S1 8 Jicui Dong_ World Local Production Forum
Session 2- Facilitating Manufacturing Ramp-up – Suppliers View
- D3 S2 2 Tony Xu_Tofflon_ Best practice for Human Vaccine
- D3 S2 3 Vibin Joseph_ BiOZEEN approach to enabling vaccine manufacturing ramp-up
- D3 S2 4 Stephanie Krieg_ DCVMN BioE
Session 3- Panel Discussion – Sustainable Manufacturing in Africa